Douglas Brash, PhD

Senior Research Scientist in Therapeutic Radiology and in Dermatology and Clinical Professor of Therapeutic Radiology

Research Departments & Organizations

Therapeutic Radiology: Radiobiology

Radiobiology & Radiotherapy

Yale Cancer Center: Radiobiology & Radiotherapy

Office of Cooperative Research

Research Interests

DNA Adducts; DNA Damage; DNA Repair; Melanoma, Experimental; Molecular Biology; Mutagenesis; Photobiology; Skin Neoplasms; Sunburn; Xeroderma Pigmentosum

Research Summary

Cancer begins as an encounter between a carcinogen and a gene. We are pinpointing these early events, which occur decades before the appearance of a tumor. Our past work on sunlight-induced mutations in tumor suppressor genes has led us to three current topics: 1) Exploring how UVB-induced apoptosis and UV-driven cell fate decisions drive a single mutant cell to clonally expand. 2) Determining rates of DNA photoproduct formation and repair across the genome, as dosimeters of a person's past UV exposure. 3) The interaction of UV and melanin in causing melanoma.

Extensive Research Description

The story thus far, from photons up to cells: UV leads to mutations at the site of DNA photoproducts (rather than elevating genomic instability); the important photoproducts are cyclobutane dimers and (6-4) photoproducts, which join adjacent cytosines or thymines; only the cytosine mutates; these unique properties create a characteristic "mutation signature" for UV that can be seen in tumors decades later; sunlight mutates the P53 and PTCH genes in non-melanoma skin cancer; P53 is required for UV-induced apoptosis, which prevents mutations; apoptosis is signaled by DNA photoproducts in actively transcribed genes and by a product of UV-irradiated melanin; another cause of apoptosis is exposure of melanin to sunlight, particularly the melanin found in blonde and red hair; and our sun-exposed skin carries about 60,000 tiny clones of P53-mutant keratinocytes. Expansion of single mutant cells into clones is due to physiology rather than a 2nd mutation: UV-induced apoptosis deletes normal progenitor cells while sparing the mutant ones. UV also tilts the progenitor cell's fate decision toward self-renewal rather than differentiation. Now, the lab is in the midst of some "functional genomics" questions:

  • How does a single mutant keratinocyte expand into a clone? We are attempting to track the clonal expansion of mutant stem cells in a living mouse.
  • What DNA regions are the most important UV targets? In addition to actively-transcribed genes, we find that telomeres are UV-sensitive and fail to repair this damage. We've developed a method to measure UV photoproducts and repair in specific genomic regions such as telomeres, and across the entire genome.
  • Is cancer development in melanoma unique because of its melanin? We are looking at how reactive oxygen and nitrogen species triggered by UV exposure and reacting with melanin affect genetic and epigenetic fidelity, as well as whether protection against these events varies between individuals due to DNA polymorphisms.


  • Melanin Photosensitization Sao Paulo, Brazil; Grenoble, France; Toyohashi, Japan (2008)

    Professor Brash studies the role of melanin photosensitization in sun-sensitivity and skin cancer in collaboration with chemists at the University of Sao Paolo, Brazil , Fujita Health University, Japan, and the French Atomic Energy Agency, Grenoble.

Edit this profile

Contact Info

Douglas Brash, PhD
Lab Location
Brash LabHunter Building
15 York Street, Ste Suite 210

New Haven, CT 06510
Mailing Address
Therapeutic RadiologyPO Box 208040
New Haven, CT 06520-8040

Curriculum Vitae

Research Image 1

Clone of p53-mutated keratinocytes in a 3D confocal image of an epidermal whole-mount of normal human skin.